Skip to main content
Earnings Labs
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc. (FHTX)

NASDAQ·Healthcare·Biotechnology

$1.97

+5.09%

Mkt Cap $126.49M

Analyst Ratings

Buy

2

Hold

3

Sell

0

Price Target (14 analysts)

$4.00

Range $2.00 – $5.00

Implied Upside

+103.6%

Consensus $4.00 vs current $1.97